Cite
IFN-beta and EIF2AK2 are potential biomarkers for interstitial lung disease in anti-MDA5 positive dermatomyositis.
MLA
Liu, Yiming, et al. “IFN-Beta and EIF2AK2 Are Potential Biomarkers for Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.” Rheumatology, vol. 62, no. 11, Nov. 2023, pp. 3724–31. EBSCOhost, https://doi.org/10.1093/rheumatology/kead117.
APA
Liu, Y., Feng, S., Liu, X., Tang, Y., Li, X., Luo, C., & Tao, J. (2023). IFN-beta and EIF2AK2 are potential biomarkers for interstitial lung disease in anti-MDA5 positive dermatomyositis. Rheumatology, 62(11), 3724–3731. https://doi.org/10.1093/rheumatology/kead117
Chicago
Liu, Yiming, Shuo Feng, Xingyue Liu, Yujie Tang, Xiaoling Li, Chengyu Luo, and Jinhui Tao. 2023. “IFN-Beta and EIF2AK2 Are Potential Biomarkers for Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.” Rheumatology 62 (11): 3724–31. doi:10.1093/rheumatology/kead117.